Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Edits
High cholesterol levels are a major risk factor for cardiovascular diseases, including...
Gene Silencing Reduces Cholesterol Levels in Mice without the Need for Gene Editing
High cholesterol levels are a major risk factor for cardiovascular diseases, including...
Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...
Next-Generation Skin Patch-based Monitoring Platform Enables Complete Freedom of Movement for Patients in Both Healthcare and Home Settings
HERZLIYA, Israel, Feb. 20, 2024 /PRNewswire/ --...
WASHINGTON, Feb. 20, 2024 /PRNewswire/ -- MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is...
Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News!
Electric vehicle emissions costs are anticipated to continue to...
Home > Press > First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple...
